Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy [PDF]
Lili Wang+6 more
openalex +1 more source
A. Majowicz+9 more
semanticscholar +1 more source
Trenonacog alfa safety, efficacy, and pharmacokinetics in previously treated pediatric hemophilia B. [PDF]
Vilchevska K+8 more
europepmc +1 more source
111. AAV7, 8, and 9 Are More Efficient and Less Immunogenic Vectors for Muscle-Directed Gene Therapy for Hemophilia B [PDF]
Lin‐Fa Wang+3 more
openalex +1 more source
Characteristics of FXa-storing platelets in hemophilia B mice and the influence of alcohol on the platelets. [PDF]
Han W+5 more
europepmc +1 more source
32. Tolerance after Neonatal Gene Transfer of a Human Factor IX-Expressing Retroviral Vector May Involve Clonal Deletion in C3H Mice and Is Effective in Hemophilia B Dogs [PDF]
Lingfei Xu+7 more
openalex +1 more source
Preclinical Evaluation of the Systemic Safety, Efficacy, and Biodistribution of a Recombinant AAV8 Vector Expressing FIX-TripleL in Hemophilia B Mice: Implications for Human Gene Therapy. [PDF]
Chou SC+11 more
europepmc +1 more source
Lipid Nanoparticle-Mediated Liver-Specific Gene Therapy for Hemophilia B. [PDF]
Lohchania B+5 more
europepmc +1 more source
Use of nonacog beta pegol during surgery in persons with hemophilia B: a case series. [PDF]
Phua CW+4 more
europepmc +1 more source
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice [PDF]
Brian D. Brown+7 more
openalex +1 more source